Do GLP-1 injections really feel different over time? Here's what's known

What did @my.journey.with.marc actually say?

Mark, a self-described GLP-1 user who says he has lost 126 pounds since August 2024, argues that "the biggest mistake people make with injections isn't what you think, it is where they're aiming it." His core claim is that GLP-1 medications are designed to go into fat tissue, not muscle, and that variability in how injections feel week to week comes down to body composition changes, injection site rotation, and technique issues like tensing up or reusing the same spot. He also says areas like "the bum or inner thigh aren't recommended" because of high muscle density and what he calls "varied results based on the research."

He is not a clinician. He is sharing personal experience. That framing matters when evaluating what follows.

Does the science back this up?

Mostly, yes, though with meaningful caveats. The subcutaneous delivery point is well-established, and injection site variation affecting absorption is documented.

GLP-1 receptor agonists like semaglutide and tirzepatide are formulated for subcutaneous injection, meaning into the fatty tissue just beneath the skin. This is not a preference, it is the pharmacokinetic basis for how the drug is absorbed. Injecting into muscle changes the absorption rate and can cause more discomfort. A 2022 review by Heise et al. in Diabetes, Obesity and Metabolism confirmed that subcutaneous depot characteristics, including tissue thickness and regional blood flow, affect insulin and GLP-1 analog absorption profiles.

The claim that body composition changes can shift the injection experience is also plausible. As someone loses significant fat mass, previously soft subcutaneous tissue in areas like the abdomen becomes thinner, which can mean the needle inadvertently reaches closer to muscle fascia. This is not speculative, it is basic anatomy applied to a dynamic body.

What did they get wrong (or right)?

The gluteal and inner thigh advice is where things get shakier. Mark says these areas "aren't recommended" and cites "the research," but the evidence is more nuanced than that.

Manufacturer labeling for Wegovy and Ozempic (semaglutide, Novo Nordisk) lists the abdomen, thigh, and upper arm as approved injection sites. The gluteal region is not listed, which supports his point there. However, the outer thigh, not the inner thigh, is a labeled site. Lumping them together without that distinction is imprecise and could steer people away from a perfectly valid option.

His claim that high-muscle areas offer "varied results based on the research" is vague to the point of being unverifiable. He does not cite a specific study, and no large randomized trial has directly compared GLP-1 absorption across these specific body sites in the context of weight loss. Credit where it is due: his practical advice about rotating sites and not tensing up is consistent with standard injection technique guidance from diabetes nursing bodies including the Forum for Injection Technique (FIT) recommendations published by Frid et al. in 2016 in Mayo Clinic Proceedings.

What should you actually know?

Injection site rotation is not optional hygiene, it affects how consistently the drug works. Lipohypertrophy, the lumpy scar tissue that builds up from reusing the same spot, is a real phenomenon that blunts drug absorption.

A 2021 study by Johansson et al. in Diabetes Technology and Therapeutics found that injecting into lipohypertrophic tissue was associated with higher glucose variability in insulin users, a mechanism that likely applies to GLP-1 analogs given shared subcutaneous pharmacokinetics. Rotating between sites, and within sites, matters.

If injections have started feeling different as your body composition changes, that is a conversation worth having with the prescriber or a diabetes educator, not just a TikTok comment section. Needle length can also be adjusted based on tissue depth. A 4mm or 5mm pen needle is standard for most adults, but thinner tissue may warrant a technique adjustment. That is a clinical decision, not a guess.

• Use labeled sites: abdomen, outer thigh, upper arm.
• Rotate within and between sites to avoid tissue buildup.
• Tensing the skin or rushing can shift needle depth. Pinch technique helps in leaner areas.
• Sharper sensation does not automatically mean a mistake, but recurring pain in one spot is worth flagging to your provider.